GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
PROTALIX BIOTHERAPEU (PLX) [hlAlert]

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system. Using its ProCellEx system, the Company is developing a pipeline of recombinant
therapeutic proteins based on its plant cell-based expression technology that target pharmaceutical markets and that rely upon known biological mechanisms of action. Its product development candidate, prGCD, is a plant cell expressed recombinant Glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. Its product pipeline includes, among other candidates, therapeutic protein candidates for the treatment of Fabry disease, a rare, genetic lysosomal disorder in humans, an acetylcholinesterase enzyme-based therapy for biodefense and intoxication treatments and an additional undisclosed therapeutic protein.
.
( Total: 13 Current Stock Recommendations )
PROTALIX BIOTHERAPEU   (13)
Hold 38% Buy 62%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
11/20/2007  
Buy
  
9/22/2009  
Buy
  
12/2/2009  
Buy
  
10/14/2010  
Buy
  
2/24/2011  
Hold
  
3/17/2011  
Buy
  
10/13/2011  
Hold
  
4/30/2012  
Hold
  
5/2/2012  
Buy
  
5/2/2012  
Hold
  
8/24/2012  
Hold
  
10/21/2013  
Buy
  
11/12/2014  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy